Moderate to Severe Crow’s Feet Lines
Before & After (7 days)
Actual Patient. Results may vary.
Moderate to Severe Frown Lines
Before & After (7 days)
Actual Patient. Results may vary.
You’ve probably heard of BOTOX® Cosmetic, but did you know: It’s the first and only FDA-approved treatment to temporarily smooth moderate to severe forehead lines, crow’s feet lines, and frown lines in adults? BOTOX® Cosmetic is a one-of-a-kind formulation—there’s nothing exactly like it!
The results are so gratifying; Botox® Cosmetic has become one of the most popular cosmetic medical procedures performed in the nation, as well as in our local area. Only BOTOX® Cosmetic gives you BOTOX® Cosmetic results. Make it part of what you do—for you!
WHAT IS BOTOX®?
BOTOX® is a highly purified muscle toxin, isolated from a certain strain of bacteria. The toxin blocks the chemical signal between the muscle and the nerve, leading to temporary paralysis of the muscle. The paralysis occurs over 1 to 5 days and peaks in two to four weeks. Results last from two to five months, depending on amount injected and your metabolism. The effect gradually wears off, allowing the dynamic wrinkle to return.
WHAT ARE ITS USES?
BOTOX® is commonly used in cosmetic procedures to give the skin a more youthful look by reducing wrinkles. But, there are some different uses for it beyond cosmetics, primarily in helping to treat hyperhidrosis. Hyperhidrosis is a condition that causes excessive sweating, and BOTOX® has been found to be a consistently effective treatment. If this is an issue for you, we can help with that, too!
DOES IT HURT?
As with any medical procedure that involves needles, you can expect some mild discomfort. But, with BOTOX®, the needles used are so small that any real pain is extremely minimal.
HOW LONG DOES IT LAST?
Botox generally lasts 2-5 months depending on your own metabolism (if you tan or are very physically active it metabolizes out faster) and the amount of correction you opt for. Per Allergan’s guidelines the sides of eyes (lateral canthus lines) takes 24 units (total for both eyes), the forehead is 20 units, and the glabellar region is 24 units (recommendations for maximum correction), it is always recommended to do the forehead and the glabellar region simultaneously to avoid drooping of eyebrows/eyes. You may opt to only do one area or opt for less units than recommended, however if you feel that you did not get the result you are desiring with less product please follow up in 14 days for more product, we do not recommend more product in less than 14 days. The results vary depending on the amount of product used and how strong your muscles are, we just want you to be aware of Allergan’s recommendations, as many people opt for less than what is recommended.
Juvedérm® Ultra XC, Ultra Plus XC, Vobella® & Voluma® are dermal fillers available from Allergan, the makers of Botox®. They are excellent fillers, especially for lips and nasolabial folds, chin and cheeks, as it tends to swell less than other fillers and generally lasts for around 12 -24 months, depending on the area being treated and with which specific product.
JUVEDÉRM® ULTRA XC
Juvedérm® Ultra XC dermal filler is a perfect option if you want fuller, plumper lips. Whether your lips have thinned over time or you’ve just always wanted fuller lips, Juvedérm® Ultra XC is an injectable gel that provides natural looking results without invasive surgery. With results that last up to a year, you can rest assured knowing you’ll have long-lasting, beautifully full lips that will leave you feeling confident and ready to take on the world.
JUVEDÉRM® ULTRA PLUS XC
For more intense lines and wrinkles, Juvedérm® Ultra Plus XC dermal fillers can help you regain that youthful exuberance. Fill in unwanted wrinkles, add volume to your cheeks, and define your lips to give your face a fuller and lifted appearance. Juvedérm® Ultra Plus XC can also help improve your skin’s texture and can enhance the production of collagen which strengthens your skin and reduces wrinkles over time. Results can last up to a year.
Juvedérm Voluma® can restore balance and heart-shaped proportions to the face by subtly adding volume to areas where this is lacking due to the effects of aging or extreme weight loss. The result is a restoration of the triangle of youth back to its original form resulting in a softer and more youthful appearance. Many people do not realize the impact that losing volume on your cheeks can have on a person as they age. Many people think of wrinkles and lip size when trying to keep their youthful look, but full cheeks are a key component to youthful beauty. The cheeks are probably the most important area to treat to restore volume and lift the mid and lower face as they are the greatest anatomical anchor on the face. Juvedérm Voluma® is the latest of the Juvedérm® range of hyaluronic acid fillers specifically designed to restore volume, lift, and contour cheeks. Additionally, due to its versatility, it is also suitable for adding definition to the jawline and chin. If you have lost some of the natural lift and facial fat loss that occurs with age or weight loss and you feel as if your face is no longer the ideal shape, a dermal filler may be the answer for you. Juvedérm Voluma® is one of the most successful products by Juvedérm® because of how effective and long-lasting the treatment is. Receiving dermal filler is a very quick process, generally between 15 minutes and an hour. Best of all, you will see results immediately and the treatment can last up to 2 years before needing reapplication.
JUVEDÉRM VOLBELLA® XC
This filler is used to add subtle, softer, more natural results to lips and to the vertical lines above the lips. Results last up to a year.
Areas of Concern:
Sun Damage, Aging, & Wrinkles
4 VI Precision Plus Peels over a 5 month period
Areas of Concern:
Sensitive Skin, Acne Marks and
Scarring, & Uneven Skin Tone
2 VI Peels over a three month period
If you have never had a peel, you are missing out! We use VI Aesthetics for our peels, which go unparalleled in the world of medical peels. VI Peel® facial peels are good for all skin types, highly effective, and are blended to reduce discomfort. These peels are multi-taskers, nurturing skin with vitamins and minerals while going through the exfoliation process. These peels are truly unique – no store-bought peel is comparable! VI Peels® are medical grade and come with an after care kit to help your skin transformation last longer. In as little as 7 days, your skin will be completely different!
VI Peel® & VI Peel with Precision®
VI Peel with Precision Plus®
VI Peel PURIFY®
VI Peel PURIFY with Precision Plus®
Microneedling (also known as collagen induction therapy) involves using fine needles to create hundreds of tiny, invisible puncture wounds in the top layer of skin. The micro-injuries created stimulate the body’s natural wound healing processes, resulting in cell turnover and increased collagen and elastin production, therefore reversing as well as preventing signs of aging, drastically reducing scarring and can help with fine lines and wrinkles. This creates long lasting results.
We use a special mechanical pen with a sterile attachment that has tiny needles that are adjusted to the proper depth for particular areas to ensure safety and results. The pain experienced during the treatment is minimal, but you will be numbed beforehand of course! If acne is a concern, a topical antibiotic can be applied to help heal acne and prevent eruptions if no allergies/contraindications apply.
Do you have moles or skin tags that are bothersome or unsightly? We can remove these permanently for you, and quickly! We use our special fibroblast pen that is able to remove these lesions precisely and accurately with little to no damage to healthy surrounding skin. Insurance does not pay for this because it is for cosmetic purposes, however we do offer fantastic cash based prices. You must have a chart on file with us prior to scheduling an appointment. Must have appointment scheduled for this procedure. For each unwanted lesion/growth removed it is $30, cash or card only. For any appointment rescheduled or canceled within 24 business hours, a $20 fee is applicable, as we would likely not be able to fill that time reserved for you with such little notice.
BOTOX® Cosmetic is the first and only FDA-approved product to temporarily improve both moderate to severe frown lines between the brows and crow’s feet lines around the sides of the eyes in adults.
BOTOX® Cosmetic targets one of the underlying causes of frown lines and crow’s feet—the repeated muscle contractions from frowning and squinting over the years. Your doctor will inject these muscles with BOTOX® Cosmetic to temporarily reduce muscle activity. You’ll begin to notice a visible smoothing of these lines.
To temporarily improve moderate to severe crow’s feet, your doctor will inject BOTOX® Cosmetic into the muscle surrounding the sides of your eyes—called the orbicularis oculi.
For temporary improvement of moderate to severe frown lines, BOTOX® Cosmetic is injected into 2 muscles—the corrugator and procerus muscles.
Treatment with BOTOX® Cosmetic takes approximately 10 minutes and requires minimal downtime or recovery—it’s often called a lunchtime procedure.
Think 2 treatments, 1 visit. Ask your doctor aboutreceiving BOTOX® Cosmetic for moderate to severe frown lines and crow’s feet at the same time.
When BOTOX® Cosmetic is administered by an experienced injector, you should not lose the ability to show expressions. BOTOX® Cosmetic is a techniquesensitive procedure that should only be performed by a licensed and trained aesthetic provider who has expertise in facial anatomy.
Talk to your doctor about your expectations and the results you want to achieve with treatment.
Do NOT consume alcoholic beverages at least 24 hours prior to treatment (alcohol may thin the blood and increase the risk of bruising).
Avoid anti-inflammatory/blood thinning medications, if possible, for a period of 5 days before treatment. Medications and supplements such as aspirin, vitamin E, ginkgo biloba, ginseng, St. John’s Wort, Omega 3/Fish Oil supplements, Ibuprofen, Motrin, Advil, Aleve and other NSAIDS have a blood thinning effect and can increase the risk of bruising and swelling after injections.
Schedule your appointment at least 2 weeks prior to a special event which you may be attending, such as a wedding or a vacation if you are anticipating needing results for pictures or for the event and also to allow any potential bruising or swelling to resolve during that time period, not everyone will have swelling or bruising (these occur for a variety of reasons, including your own blood/genetic factors) and cannot always be anticipated.
Discontinue Retin-A or similar medications 2 days before and 2 days after treatment.
BOTOX® Cosmetic (onabotulinumtoxinA) Important Information
BOTOX® Cosmetic (onabotulinumtoxinA) is indicated in adult patients for the temporary improvement in the appearance of:
– moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity
– moderate to severe lateral canthal lines associated with orbicularis oculi activity
– moderate to severe forehead lines associated with frontalis activity
IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING
WARNING: DISTANT SPREAD OF TOXIN EFFECT
Postmarketing reports indicate that the effects of BOTOX® Cosmetic and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have an underlying condition that would predispose them to these symptoms. In unapproved uses, including spasticity in children, and in approved indications, cases of spread of effect have been reported at doses comparable to those used to treat cervical dystonia and spasticity and at lower doses.
BOTOX® Cosmetic is contraindicated in the presence of infection at the proposed injection site(s) and in individuals with known hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation.
WARNINGS AND PRECAUTIONS
Lack of Interchangeability between Botulinum Toxin Products
The potency Units of BOTOX® Cosmetic are specific to the preparation and assay method utilized. They are not interchangeable with other preparations of botulinum toxin products and, therefore, units of biological activity of BOTOX® Cosmetic cannot be compared to nor converted into units of any other botulinum toxin products assessed with any other specific assay method.
Spread of Toxin Effect
Please refer to Boxed Warning for Distant Spread of Toxin Effect.
No definitive serious adverse event reports of distant spread of toxin effect associated with dermatologic use of BOTOX® Cosmetic at the labeled dose of 20 Units (for glabellar lines), 24 Units (for lateral canthal lines), 40 Units (for forehead lines with glabellar lines), 44 Units (for simultaneous treatment of lateral canthal lines and glabellar lines), and 64 Units (for simultaneous treatment of lateral canthal lines, glabellar lines, and forehead lines) have been reported.
Serious Adverse Reactions With Unapproved Use
Serious adverse reactions, including excessive weakness, dysphagia, and aspiration pneumonia, with some adverse reactions associated with fatal outcomes, have been reported in patients who received BOTOX® injections for unapproved uses. In these cases, the adverse reactions were not necessarily related to distant spread of toxin, but may have resulted from the administration of BOTOX® to the site of injection and/or adjacent structures. In several of the cases, patients had pre-existing dysphagia or other significant disabilities. There is insufficient information to identify factors associated with an increased risk for adverse reactions associated with the unapproved uses of BOTOX®. The safety and effectiveness of BOTOX® for unapproved uses have not been established.
Serious and/or immediate hypersensitivity reactions have been reported. These reactions include anaphylaxis, serum sickness, urticaria, soft-tissue edema, and dyspnea. If such reactions occur, further injection of BOTOX® Cosmetic should be discontinued and appropriate medical therapy immediately instituted. One fatal case of anaphylaxis has been reported in which lidocaine was used as the diluent and, consequently, the causal agent cannot be reliably determined.
There have been reports following administration of BOTOX® of adverse events involving the cardiovascular system, including arrhythmia and myocardial infarction, some with fatal outcomes. Some of these patients had risk factors including pre-existing cardiovascular disease. Use caution when administering to patients with pre-existing cardiovascular disease.
Increased Risk of Clinically Significant Effects with Pre-existing Neuromuscular Disorders
Individuals with peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, or neuromuscular junction disorders (eg, myasthenia gravis or Lambert-Eaton syndrome) should be monitored when given botulinum toxin. Patients with neuromuscular disorders may be at increased risk of clinically significant effects including generalized muscle weakness, diplopia, ptosis, dysphonia, dysarthria, severe dysphagia, and respiratory compromise from onabotulinumtoxinA (see Warnings and Precautions).
Dysphagia and Breathing Difficulties
Treatment with BOTOX® and other botulinum toxin products can result in swallowing or breathing difficulties. Patients with pre-existing swallowing or breathing difficulties may be more susceptible to these complications. In most cases, this is a consequence of weakening of muscles in the area of injection that are involved in breathing or oropharyngeal muscles that control swallowing or breathing (see Boxed Warning).
Pre-existing Conditions at the Injection Site
Caution should be used when BOTOX® Cosmetic treatment is used in the presence of inflammation at the proposed injection site(s) or when excessive weakness or atrophy is present in the target muscle(s).
Human Albumin and Transmission of Viral Diseases
This product contains albumin, a derivative of human blood. Based on effective donor screening and product manufacturing processes, it carries an extremely remote risk for transmission of viral diseases and variant Creutzfeldt-Jakob disease (vCJD). There is a theoretical risk for transmission of Creutzfeldt-Jakob disease (CJD), but if that risk actually exists, the risk of transmission would also be considered extremely remote. No cases of transmission of viral diseases, CJD or vCJD have ever been identified for licensed albumin or albumin contained in other licensed products.
The most frequently reported adverse reaction following injection of BOTOX® Cosmetic for glabellar lines was eyelid ptosis (3%).
The most frequently reported adverse reaction following injection of BOTOX® Cosmetic for lateral canthal lines was eyelid edema (1%).
The most frequently reported adverse reactions following injection of BOTOX® Cosmetic for forehead lines with glabellar lines were headache (9%), brow ptosis (2%) and eyelid ptosis (2%).
Co-administration of BOTOX® Cosmetic and aminoglycosides or other agents interfering with neuromuscular transmission (eg, curare-like compounds) should only be performed with caution as the effect of the toxin may be potentiated. Use of anticholinergic drugs after administration of BOTOX® Cosmetic may potentiate systemic anticholinergic effects.
The effect of administering different botulinum neurotoxin products at the same time or within several months of each other is unknown. Excessive neuromuscular weakness may be exacerbated by administration of another botulinum toxin prior to the resolution of the effects of a previously administered botulinum toxin.
Excessive weakness may also be exaggerated by administration of a muscle relaxant before or after administration of BOTOX® Cosmetic.
USE IN SPECIFIC POPULATIONS
There are no studies or adequate data from postmarketing surveillance on the developmental risk associated with use of BOTOX® Cosmetic in pregnant women. There are no data on the presence of BOTOX® Cosmetic in human or animal milk, the effects on the breastfed child, or the effects on milk production.
The JUVÉDERM® range of fillers can correct age-related loss in the cheeks, lips, lip lines, and other facial wrinkles and folds in individuals over the age of 21.
JUVÉDERM® is the world’s #1 selling dermal filler collection, and with good reason! JUVÉDERM® is FDA-Approved, so you can rest assured that it is safe. Using JUVÉDERM® offers:
JUVÉDERM® Collection of Fillers Important Information
JUVÉDERM VOLUMA® XC injectable gel is indicated for deep (subcutaneous and/or supraperiosteal) injection for cheek augmentation to correct age-related volume deficit in the mid-face in adults over the age of 21.
JUVÉDERM® Ultra XC and JUVÉDERM® Ultra Plus XC injectable gels are indicated for injection into the mid-to-deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds).
JUVÉDERM VOLLURE™ XC injectable gel is indicated for injection into the mid-to-deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds) in adults over the age of 21.
JUVÉDERM® Ultra XC injectable gel is indicated for injection into the lips and perioral area for lip augmentation in adults over the age of 21.
JUVÉDERM VOLBELLA® XC injectable gel is indicated for injection into the lips for lip augmentation and for correction of perioral rhytids in adults over the age of 21.
IMPORTANT SAFETY INFORMATION
These products should not be used in patients who have severe allergies, marked by a history of anaphylaxis or history or presence of multiple severe allergies, and should not be used in patients with a history of allergies to Gram-positive bacterial proteins or lidocaine contained in these products.
Do not inject into blood vessels. Introduction of these products into the vasculature may lead to embolization, occlusion of the vessels, ischemia, or infarction. Take extra care when injecting soft-tissue fillers; for example, inject the product slowly and apply the least amount of pressure necessary. Rare, but serious, adverse events associated with the intravascular injection of soft-tissue fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage leading to stroke, skin necrosis, and damage to underlying facial structures. Immediately stop the injection if a patient exhibits any of the following symptoms: changes in vision, signs of a stroke, blanching of the skin, unusual pain during or shortly after the procedure. Patients should receive prompt medical attention and, possibly, evaluation by an appropriate healthcare professional specialist should an intravascular injection occur
Product use at specific sites in which an active inflammatory process (skin eruptions such as cysts, pimples, rashes, or hives) or infection is present should be deferred until the underlying process has been controlled
In order to minimize the risk of potential complications, these products should only be used by healthcare professionals who have appropriate training, experience, and knowledge of facial anatomy
Healthcare professionals are encouraged to discuss the potential risks of soft-tissue injections with their patients prior to treatment and ensure that patients are aware of signs and symptoms of potential complications
The safety and effectiveness for the treatment of anatomic regions other than the mid-face with JUVÉDERM VOLUMA® XC; facial wrinkles and folds with JUVÉDERM® Ultra XC, JUVÉDERM® Ultra Plus XC, and JUVÉDERM VOLLURE™ XC; and the lips and perioral area with JUVÉDERM® Ultra XC and JUVÉDERM VOLBELLA® XC have not been established in controlled clinical studies
As with all transcutaneous procedures, dermal filler implantation carries a risk of infection. Follow standard precautions associated with injectable materials
The safety for use during pregnancy, in breastfeeding females, and in patients with known susceptibility to keloid formation, hypertrophic scarring, and pigmentation disorders has not been studied
The safety for use of JUVÉDERM VOLUMA® XC in patients under 35 or over 65 years, JUVÉDERM® Ultra XC and JUVÉDERM® Ultra Plus XC in patients under 18 years, and JUVÉDERM VOLLURE™ XC and JUVÉDERM VOLBELLA® XC in patients under 22 years has not been established
Use with caution in patients on immunosuppressive therapy
Patients who are using products that can prolong bleeding (such as aspirin, nonsteroidal anti-inflammatory drugs, and warfarin) may experience increased bruising or bleeding at treatment sites
If laser treatment, chemical peel, or any other procedure based on active dermal response is considered after treatment, or if these products are administered before the skin has healed completely, there is a possible risk of an inflammatory reaction at the treatment site
Patients who experience skin injury near the site of implantation may be at a higher risk for adverse events
The safety of JUVÉDERM VOLUMA® XC injectable gel for use in patients with very thin skin in the mid-face has not been established
Patients may experience late onset nodules with use of dermal fillers, including JUVÉDERM VOLUMA® XC
Patients may experience late onset adverse events with use of dermal fillers
The most commonly reported side effects for JUVÉDERM® injectable gels were injection-site redness, swelling, pain, tenderness, firmness, lumps/bumps, bruising, discoloration, and itching. For JUVÉDERM VOLBELLA® XC, dryness was also reported. For JUVÉDERM VOLUMA® XC, side effects were predominantly moderate in severity, with duration of 2 to 4 weeks; for JUVÉDERM® Ultra XC, JUVÉDERM® Ultra Plus XC, or JUVÉDERM VOLLURE™ XC, they were mostly mild or moderate in severity, with duration of 14 days or less; and for JUVÉDERM VOLBELLA® XC, they were predominantly mild or moderate, with duration of 30 days or less.
To report an adverse reaction with any product in the JUVÉDERM® Collection, please call Allergan at 1-800-433-8871. Please visit JuvedermDFU.com for more information.
Products in the JUVÉDERM® Collection are available by prescription only.